Nectar Lifescience Ltd Performance
- ₹41.8Day's Price Range₹41.8
52 Week's Low
52 Week's High
₹26.1552-Week Price Range₹56.5
| Returns % | |
| 1 Month Return | + 24.45 % |
| 3 Month Return | + 2.62 % |
| 1 Year Return | + 24.92 % |
| Market Stats | |
| Previous Close | ₹42.66 |
| Open | ₹41.80 |
| Volume | 9.19L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹976.43Cr |
Nectar Lifescience Ltd Key Statistics
| P/E Ratio | 88.87 |
| PEG Ratio | 148.12 |
| Market Cap | ₹976.43 Cr |
| P/B Ratio | 0.63 |
| EPS | 0.22 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 0.47 |
Nectar Lifescience Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹976.43 Cr | 46.14% | 0.69 | ₹5 Cr | ₹1,684 Cr | |
| NA | ₹435.76 Cr | 272.24% | 0.54 | ₹28 Cr | ₹601 Cr | |
| NA | ₹15.41 Cr | 278.33% | 0.50 | NA | NA | |
| BUY | ₹23,100.09 Cr | 3.59% | 0.52 | NA | NA | |
| NA | ₹706.49 Cr | -0.07% | 0.57 | ₹9 Cr | ₹179 Cr |
About Nectar Lifescience Ltd
Share Price: ₹41.80 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹976.43Cr as of today
Revenue: ₹427.88Cr as on September 2024 (Q3 24)
Net Profit: ₹5.60Cr as on September 2024 (Q3 24)
Listing date: 18 Jul, 2005
Chairperson Name: Sanjiv Goyal
| Organisation | Nectar Lifescience Ltd |
| Headquarters | Chandigarh |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Nectar Lifescience Ltd
Nectar Lifescience Reports Strong Q3 Growth - 28 Nov, 2024
Nectar Lifescience reported a 7.57% increase in net sales to Rs 428.10 crore for September 2024, with net profit soaring 451.45% to Rs 5.60 crore. EBITDA rose 17.48%, and EPS increased to Rs 0.25. The stock has shown stable performance with 8.20% returns over the last year.Nectar Lifescience Reports Strong Q3 Growth - 26 Nov, 2024
Nectar Lifescience's standalone net sales for September 2024 reached Rs 428.10 crore, up 7.57% YoY. Net profit surged 451.45% to Rs 5.60 crore, with EBITDA rising 17.48%. EPS increased to Rs 0.25 from Rs 0.05. Shares closed at Rs 32.95 on November 25, 2024.Nectar Lifesciences Faces ITC Discrepancy Challenge - 21 Nov, 2024
Nectar Lifesciences is facing a challenge regarding a ₹1.01 crore discrepancy in Input Tax Credit (ITC) for FY 2021-22. The Asst. Commissioner ruled that the company availed excess ITC, which is deemed ineligible. The company plans to appeal the decision.
Insights on Nectar Lifescience Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, NECLIFE stock has moved up by 18.0%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 359.85 Cr → 428.79 Cr (in ₹), with an average increase of 16.1% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 0.59 Cr → 5.6 Cr (in ₹), with an average increase of 63.6% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 1.66% to 2.57% in Sep 2024 quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 21.91% to 32.54% in Sep 2024 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 44.35% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 57.1% return, outperforming this stock by 11.5%
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 135.8% return, outperforming this stock by 70.5%
Nectar Lifescience Ltd Financials
Nectar Lifescience Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 44.35% | 0.00 | |
| Foreign Institutions | 2.57% | 55.34 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 32.54% | 48.50 | |
| Others | 20.53% |
Nectar Lifescience Ltd Key Indicators
Nectar Lifescience Ltd Valuation
Nectar Lifescience Ltd in the last 5 years
Lowest (-284.58x)
December 21, 2023
Industry (56.23x)
December 19, 2024
Today (88.87x)
December 19, 2024
Highest (403.33x)
August 26, 2020
Nectar Lifescience Ltd Earnings and Dividends
Nectar Lifescience Ltd Earnings Results
Nectar Lifescience Ltd’s net profit jumped 449.02% since last year same period to ₹5.60Cr in the Q2 2024-2025. On a quarterly growth basis, Nectar Lifescience Ltd has generated 88.55% jump in its net profits since last 3-months.
Read More about Earnings ResultsNectar Lifescience Ltd Dividends July,2020
In the quarter ending June 2020, Nectar Lifescience Ltd has declared dividend of ₹0.05 - translating a dividend yield of 0.12%.
Read More about Dividends
Nectar Lifescience Ltd Technicals Summary
Bearish
Neutral
Bullish
Nectar Lifescience Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Nectar Lifescience Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Nectar Lifescience Ltd shares.
Nectar Lifescience Ltd (NECLIFE) share price today is ₹41.8
Nectar Lifescience Ltd is listed on NSE
Nectar Lifescience Ltd is listed on BSE
- Today’s highest price of Nectar Lifescience Ltd is ₹41.8.
- Today’s lowest price of Nectar Lifescience Ltd is ₹41.8.
PE Ratio of Nectar Lifescience Ltd is 88.87
PE ratio = Nectar Lifescience Ltd Market price per share / Nectar Lifescience Ltd Earnings per share
Today’s traded volume of Nectar Lifescience Ltd(NECLIFE) is 9.19L.
Today’s market capitalisation of Nectar Lifescience Ltd(NECLIFE) is ₹976.43Cr.
| Nectar Lifescience Ltd(NECLIFE | Price |
|---|---|
52 Week High | ₹56.5 |
52 Week Low | ₹26.15 |
Nectar Lifescience Ltd(NECLIFE) share price is ₹41.8. It is down -26.02% from its 52 Week High price of ₹56.5
Nectar Lifescience Ltd(NECLIFE) share price is ₹41.8. It is up 59.85% from its 52 Week Low price of ₹26.15
| Nectar Lifescience Ltd(NECLIFE | Returns |
|---|---|
1 Day Returns | -0.86% |
1 Month Returns | 24.45% |
3 Month Returns | 2.62% |
1 Year Returns | 24.92% |